RESEARCH

Underreporting in pharmacovigilance: Where do we go from here?

While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions

18 February 2026

AI meets psychedelic storytelling: What online forums can teach pharmacovigilance

Online psychedelic forums hold untapped safety data. AI analysis of user narratives could help pharmacovigilance systems detect risks missed by traditional reporting.

13 November 2025

Revisiting the role of medication utilisation evaluations to assess adherence to risk minimisation measures

MUEs are typically used to improve the safety of drugs, however, may they also have a role in measuring the adherence to risk minimisation measures?

06 August 2025

Beyond numbers, quality in ADR reporting – New podcast episode

Spontaneous adverse event reports pose significant challenges to pharmacovigilance scientists. How may we turn them into opportunities that benefit our pharmacovigilance systems?

04 June 2025